Impact of systemic inflammatory markers on the response to Hyperthermic IntraVEsical Chemotherapy (HIVEC) in patients with non-muscle-invasive bladder cancer after bacillus Calmette

Impact of systemic inflammatory markers on the response to Hyperthermic IntraVEsical Chemotherapy (HIVEC) in patients with non-muscle-invasive bladder cancer after bacillus Calmette–Guérin failure

Published:2021-01-02 Issue:1 Volume:19 Page:86-91
ISSN:2090-598X
Container-title:Arab Journal of Urology
language:en
Short-container-title:Arab Journal of Urology

Author:

Chiancone Francesco¹^ORCID,Fabiano Marco¹^ORCID,Carrino Maurizio¹,Fedelini Maurizio¹,Meccariello Clemente¹,Fedelini Paolo¹

Affiliation:

1. Department of Urology, Azienda Ospedaliera di Rilievo Nazionale (A.O.R.N.) Antonio Cardarelli, Naples, Italy

Publisher

Informa UK Limited

Subject

Urology

Link

https://www.tandfonline.com/doi/pdf/10.1080/2090598X.2021.1874627

Reference30 articles.

1. EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016

2. Laparoscopic radical cystectomy with extracorporeal urinary diversion: an Italian single-center experience with 10-year outcomes

3. Treatment Paradigm Shift May Improve Survival of Patients With High Risk Superficial Bladder Cancer

4. Bladder-preserving strategies for Bacillus Calmette-Guérin unresponsive non-muscle invasive bladder cancer; where are we and what will be expected?

5. Systematic Review of the Therapeutic Efficacy of Bladder-preserving Treatments for Non–muscle-invasive Bladder Cancer Following Intravesical Bacillus Calmette-Guérin

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HIVEC as an alternative option in non-muscle-invasive bladder cancer: Experiences from a high-volume center;Urologic Oncology: Seminars and Original Investigations;2024-08

2. Device-assisted intravesical chemotherapy treatment for nonmuscle invasive bladder cancer: 2022 update;Current Opinion in Urology;2022-06-24

3. Nicht-muskelinvasives Harnblasenkarzinom (NMIBC) – Rezidivprophylaxe bei geringem und intermediärem Risiko;Der Urologe;2021-10-15

4. Application of intra-arterial chemotherapy in high-risk non-muscle invasive bladder cancer: a systematic review and meta-analysis;PeerJ;2021-09-28